Studio Clinico Preliminare Dell'Attivita’ Del Diidrossiprogesterone Acetofenide Nel Carcinoma Prostatico

Bracci U. : Our present procedures in the treatment of prostatic cancer. In: Hormonal therapy of prostatic cancer. Proc. Intern. Meeting Rome, pag. 176–192 (1975).

Denis L. , Declerq H. : Progestagens in prostatic cancer. Int. Conf. Prostatic Cancer. Leeds, pag. 247–250 (1976).

Lerner L. J. , Brennan D. M. , Borman A. : Biological activies of 16 alfa, 17 beta, dihiydroxyprogesterone derivatives. Proc. Soc. Exp. Biol. Med., 106; 231–234 (1961).

Rafla S. , Johnson R. : The treatment of advanced prostatic carcinoma with medroxyprogesterone. Curr. Res., 16; 261–267 (1974).

Shearer R. J. , Hendry W. F. , Sommerville I. F. : Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer. Brit. J. Urol., 45; 688–692 (1973).

VACURG: Carcinoma of the prostate: treatment comparisons. J. Urol., 98; 516–520 (1967).